Latest SLNO reports update at 2023-08-08: 2023-Q22023-Q12022-Q4
Soleno Therapeutics logo

Soleno Therapeutics SLNO

$ 45.12 -8.35%

Country

usaUSA

IPO year

2014

Industry

Diagnostics research

Stock Exchange

NASDAQ CAPITAL

CEO

DR. Anish Bhatnagar

Employees in the company

13

Shares

8.4 M

Market Cap[1]

$ 379 M

EBITDA (LTM)

$ -23.8 M

P/E (LTM)

-1.62

P/S (LTM)

-

EPS (LTM)

-3.17

Other stocks of industry "Diagnostics research"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.